申请人:E. R. Squibb & Sons, Inc.
公开号:US05059690A1
公开(公告)日:1991-10-22
Antiviral activity is exhibited by compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof wherein R.sub.1 is a purine or pyrimidine base or an analog thereof and R.sub.2 and R.sub.3 are independently hydrogen, --PO.sub.3 H.sub.2 or ##STR2## wherein X.sub.7 is hydrogen, alkyl, substituted alkyl or aryl.
化合物具有以下结构式的抗病毒活性:##STR1##及其药学上可接受的盐,其中R.sub.1是嘌呤或嘧啶碱基或其类似物,R.sub.2和R.sub.3分别是氢、--PO.sub.3 H.sub.2或##STR2##其中X.sub.7是氢、烷基、取代烷基或芳基。